About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Heme Tumor Board: 78 y/o Male With Newly Diagnosed Monoclonal Gammopathy of Renal Significance Presenting for Second Opinion
By
PrecisCa
FEATURING
Daniel Pollyea
,
Ajay Nooka
,
Peter Forsberg
,
David Schuster
By
PrecisCa
FEATURING
Daniel Pollyea
,
Ajay Nooka
,
Peter Forsberg
,
David Schuster
120 views
December 15, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Related Content
AUTOPLAY
ON
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
41:54
University of Colorado Division of Hematology
Overview of Pathophysiology, Diagnosis and Management of Multiple My…
Feat.
K. Sidor
10:23
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …
Feat.
T. Einarsson Long
27:06
Moffitt Cancer Center
Hot Off the Press: Experts Discuss the Latest Data in Plasma Cell Dy…
Feat.
R. Baz,
M. Alsina,
K. Shain,
A. Grajales-Cruz
20:28
Dana-Farber Cancer Institute
The PROMISE of Early Detection and Interception in Myeloma
Feat.
I. Ghobrial
26:58
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis
Feat.
S. Susanibar-Adaniya
44:53
MyCancerHaven
Experts Discuss MGUS and Smoldering Myeloma
Feat.
R. Vij,
P. Kapoor
12:32
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Early Benefits and Psychological Effects of…
Feat.
S. Rögnvaldsson
41:46
Yale Cancer Center
Early Detection and Interception in Myeloma: The PROMISE Study
Feat.
I. Ghobrial
23:42
GRACE
Multiple Myeloma & Cellular Therapies: A Patient-Centric Primer
Feat.
S. Rajeeve
10:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "MGUS and the Risk of Thrombotic Events - Re…
Feat.
S. Rögnvaldsson
22:16
SOHO Italy 1st School of Multiple Myeloma
Molecular Pathogenesis of MM: MGUS and SMM, Genomic Complexity of th…
Feat.
N. Bolli
20:17
Indy Hematology Review
Therapy for Newly Diagnosed Myeloma - Role of Transplant and MRD, DA…
Feat.
K. Anderson
54:04
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
MGUS: Disease Definitions, Diagnostic Approaches and Risk Stratifica…
Feat.
M. Gertz
22:20
SOHO Italy 1st School of Multiple Myeloma
Single-Cell Characterization of the BM Immune Microenvironment in MM…
Feat.
C. Botta
19:12
SOHO Italy 1st School of Multiple Myeloma
1st/2nd Relapse in MM: Predictive Factors, EMD, Role of sFLC in MGUS…
Feat.
U. Markovic
19:16
Memorial Sloan Kettering Cancer Center
Should Smoldering Myeloma Be Treated?
Feat.
O. Landgren
16:11
Natalie Callander
MGUS: Risk Stratification and Therapeutic Options
16:38
SOHO Italy 1st School of Multiple Myeloma
Extracellular Vesicles in Myeloma: What Is Their Role in MGUS-to-MM …
Feat.
A. Reale
13:27
Shaji Kumar
Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma
